Rhenman & Partners Asset Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-117,265
| Closed | -$1.46M | – | 96 |
|
|
2019
Q1 | $1.46M | Sell |
117,265
-389,700
| -77% | -$4.86M | 0.17% | 72 |
|
|
2018
Q4 | $5.74M | Sell |
506,965
-25,847
| -5% | -$293K | 0.66% | 55 |
|
|
2018
Q3 | $9.97M | Buy |
532,812
+181,026
| +51% | +$3.39M | 1% | 48 |
|
|
2018
Q2 | $9.09M | Buy |
351,786
+115,100
| +49% | +$2.98M | 0.93% | 49 |
|
|
2018
Q1 | $5.3M | Sell |
236,686
-25,000
| -10% | -$560K | 0.65% | 53 |
|
|
2017
Q4 | $6.55M | Buy |
+261,686
| New | +$6.55M | 0.89% | 46 |
|